These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 36757164)

  • 1. Risk of Mortality in Bone Marrow Transplant Patients During SARS-CoV-2 Infection: A Systematic Review.
    Karhana S; Hussain K; Bint-E-Attar G; Bhurani D; Khan MA
    Exp Clin Transplant; 2023 Jan; 21(1):1-11. PubMed ID: 36757164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
    Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection in heart transplant recipients: a systematic literature review of clinical outcomes and immunosuppression strategies.
    Ilonze OJ; Ballut K; Rao RS; Jones MA; Guglin M
    Heart Fail Rev; 2022 Sep; 27(5):1653-1663. PubMed ID: 34671872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Cohort Study of Indian Centers on Reoccurring SARS-CoV-2 Infections in Kidney Transplant Recipients.
    Kute VB; Hegde U; Das P; Sharma A; Bahadur MM; Sil K; Guleria S; Varma PP; Jamale T; Meshram HS
    Exp Clin Transplant; 2021 Oct; 19(10):1023-1031. PubMed ID: 34498549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and solid organ transplantation: Finding the right balance.
    Opsomer R; Kuypers D
    Transplant Rev (Orlando); 2022 Jul; 36(3):100710. PubMed ID: 35809422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak.
    Bottio T; Bagozzi L; Fiocco A; Nadali M; Caraffa R; Bifulco O; Ponzoni M; Lombardi CM; Metra M; Russo CF; Frigerio M; Masciocco G; Potena L; Loforte A; Pacini D; Faggian G; Onorati F; Sponga S; Livi U; Iacovoni A; Terzi A; Senni M; Rinaldi M; Boffini M; Marro M; Jorgji V; Carrozzini M; Gerosa G
    JACC Heart Fail; 2021 Jan; 9(1):52-61. PubMed ID: 33309578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low mortality in SARS-CoV-2 infected heart transplant recipients at a single center.
    Duran JM; Barat M; Lin AY; King KR; Greenberg B; Adler ED; Aslam S
    Clin Transplant; 2022 Jan; 36(1):e14443. PubMed ID: 34320235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe sepsis in hematopoietic stem cell transplant recipients*.
    Kumar G; Ahmad S; Taneja A; Patel J; Guddati AK; Nanchal R;
    Crit Care Med; 2015 Feb; 43(2):411-21. PubMed ID: 25599465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample.
    Hasan I; Rashid T; Suliman S; Amer H; Chirila RM; Mai ML; Jarmi T; Khouzam S; Franco PM; Heilig CW; Wadei HM
    Rom J Intern Med; 2021 Mar; 59(1):10-42. PubMed ID: 33155999
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical characteristics and outcome of coronavirus disease 2019 infection in patients with solid organ transplants: A systematic review and meta-analysis.
    An W; Wang Q; Kim TE; Kang JS
    J Infect Public Health; 2022 Mar; 15(3):365-372. PubMed ID: 35193818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.
    Fisher SA; Cutler A; Doree C; Brunskill SJ; Stanworth SJ; Navarrete C; Girdlestone J
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009768. PubMed ID: 30697701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus disease 2019 outcomes in heart transplant recipients: A large Australian cohort.
    Cherrett C; Cao J; Adams C; Macdonald P
    J Heart Lung Transplant; 2024 Feb; 43(2):346-349. PubMed ID: 37716497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium.
    Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Pérez-Sáez MJ; Redondo-Pachón MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV
    Am J Transplant; 2020 Nov; 20(11):3140-3148. PubMed ID: 32649791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis.
    Fraser J; Mousley J; Testro A; Smibert OC; Koshy AN
    Transplant Proc; 2020 Nov; 52(9):2676-2683. PubMed ID: 32891405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulators for severe coronavirus disease-2019 in transplant patients: Do they increase the risk of secondary infection?
    Mendoza MA; Ranganath N; Chesdachai S; Yetmar ZA; Razonable R; Abu Saleh O
    Transpl Infect Dis; 2023 Apr; 25(2):e14050. PubMed ID: 36852753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.